| Literature DB >> 26605352 |
Samuel Arba Mosquera1, Jorge L Alió2.
Abstract
PURPOSE: The aim of this systematic review was to synthesize and appraise the evidence of the benefits of presbyopic correction on the cornea for visual function.Entities:
Keywords: Corneal multifocality; Corneal pseudoaccommodation; Distance corrected near visual acuity; KAMRA; Laser Blended Vision; Monovision; PresbyMAX; Presbylasik; Presbyopic refractive correction; Supracor and Intracor
Year: 2014 PMID: 26605352 PMCID: PMC4604121 DOI: 10.1186/s40662-014-0005-z
Source DB: PubMed Journal: Eye Vis (Lond) ISSN: 2326-0254
Summary of clinical studies in monovision
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Goldberg [ | 114 | >6M | 76% > 20/25 | 96% > J2 | 13% | 2% |
| Goldberg [ | 137 | >6M | 89% > 20/25 | 99% > J2 | 15% | 6% |
| Braun et al. [ | 172 | --- | --- | --- | 28% | 7% |
| Garcia-Gonzalez M. et al. [ | 37 | --- | 20/19 | J1 | --- | --- |
| Ito M et al. [ | 54 | 5Y | 20/20 | J1 | --- | --- |
| 98% > 20/25 | 76% > J2 | |||||
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, M: months, Y: years, J: Jaeger scale for near vision.
Summary of clinical studies in multifocal ablations
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Vinciguerra et al. [ | 3 | 2Y | --- | J3 100% | --- | --- | --- | --- | --- |
| Alió et al. [ | 50 | 6M | 20/20 | J4 | J5 | 14% < −2lns | 14% < −2lns | 64% ± 0.5DS | 12% |
| 88% > 20/25 | 92% > J3 | 28% > J3 | |||||||
| Jung SW et al. [ | 28 | 6M | 93% > 20/25 | 64% > J3 | --- | --- | --- | --- | --- |
| Epstein and Gurgos [ | 103 | 1Y | 74% > 20/25 | 74% > J2 | --- | --- | --- | --- | 28% |
| Jackson et al. [ | 50 | 1Y | 100% > 20/25 | 86% > J2 | 70% > +2lns | 10% < −2lns | 8% < −2lns | 88% ± 0.5DS | --- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, Refr.Outc.: refractive outcome, Retreat.: retreatment rate, M: months, Y: year(s), J: Jaeger scale for near vision, lns: Snellen lines, DS: dioptre sphere.
Summary of clinical studies in Supracor
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| O’Keefe et al. [ | 46 | 6M | 20/23 | J3 | --- | 7% < −2lns | --- | 54% ± 0.5DS | 13% |
| 78% > 20/25 | 91% > J3 | 46% ± 0.5DC | |||||||
| Cosar CB et al. [ | 123 | 6M | 20/23 | J2 | --- | 11% < −2lns | 0% < −2lns | --- | --- |
| 37% > 20/25 | 89% > J2 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, Refr. Outc.: refractive outcome, Retreat.: retreatment rate, M: months, J: Jaeger scale for near vision, lns: Snellen lines, DS: dioptre sphere, DC: dioptre cylinder.
Summary of clinical studies in PresbyMAX
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Uthoff et al. [ | 60 | 6M | 20/21 | J3 | --- | 13% < −2lns | 0% < −2lns | 73% ± 0.5DS | 0% | 0% |
| 83% > 20/25 | 43% > J2 | |||||||||
| Luger et al. [ | 66 | 1Y | 20/23 | J1 | J3 | 3% < −2l ns | 8% < −2 lns | 73% ± 0.5DS | 0% | 0% |
| 70% > 20/25 | 84% > J2 | 93% ± 0.5DC | ||||||||
| Baudu [ | 716 | 6M | 20/25 | J1 | J2 | 6% < −2l ns | 1% < −2 lns | 88% ± 0.5DS | 14% | <1% |
| 76% > 20/25 | 90% > J2 | 99% ± 0.5DC | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity; CNVA: corrected near visual acuity, Refr. Outc.: refractive outcome; Retreat.: retreatment rate, Revers.: percentage of reverse treatment, M: months, Y: year, J: Jaeger scale for near vision, lns: Snellen lines, DS: dioptre sphere, DC: dioptre cylinder.
Summary of clinical studies in Intracor
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Ruiz LA et al. [ | 83 | 6M | 20/20 89% > 20/25 | J2 100% > J2 | J2 | 2% < −2lns | --- |
| Holzer et al. [ | 25 | 3M | 20/22 83% > 20/25 | J4 43% > J2 | J3 | 8% < −2lns | --- |
| Mike P. Holzer et al. [ | 58 | 1Y | 20/25 61% > 20/25 | J3 40% > J2 | --- | 7% < −2lns | 11% < −2lns |
| Menassa N et al. [ | 23 | 18M | 20/32 | J3 | --- | 26% < −2lns | --- |
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity; n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, M: months, Y: year, J: Jaeger scale for near vision, lns: Snellen lines.
Summary of clinical studies in KAMRA
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Dexl AK et al. [ | 32 | 2Y | 20/16 | J3 | --- | --- | --- | --- | --- |
| Yılmaz et al. [ | 22 | 4Y | 96% > 20/25 | 96% > J2 | --- | 5% < −2lns | --- | --- | 18% |
| Dexl AK et al. [ | 24 | 1Y | 20/16 100% > 20/25 | J2 92% > J3 | --- | 4% < −2lns | 8% < −2lns | 0% | 0% |
| Tomita M et al. [ | 64 | 6M | 20/19 86% > 20/25 | J2 60% > J2 | --- | 5% < −2lns | 2% < −2lns | 1% | --- |
| Dexl et al. [ | 24 | 2Y | 20/16 | J4 | --- | 4% < −2lns | --- | 0% | 0% |
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, Retreat.: retreatment rate, M: months, Y: year(s), J: Jaeger scale for near vision, lns: Snellen lines.
Summary of clinical studies in laser blended vision
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Reinstein et al. [ | 272 | 1Y | 20/17 | J3 | --- | 0% < −2lns | --- | 92% ± 0.5DS | 19% |
| 99% > 20/25 | 96% > J3 | 92% ± 0.5DC | |||||||
| Reinstein et al. [ | 222 | 1Y | 20/18 | J4 | --- | 0% < −2lns | --- | 79% ± 0.5DS | 22% |
| 99% > 20/25 | 81% > J3 | 82% ± 0.5DC | |||||||
| Reinstein et al. [ | 176 | 1Y | 20/17 | J3 | --- | 0% < −2lns | --- | 92% ± 0.5DS | 16% |
| 99% > 20/25 | 95% > J3 | 85% ± 0.5DC | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, Refr. Outc.: refractive outcome, Retreat.: retreatment rate, Y: year, J: Jaeger scale for near vision, lns: Snellen lines, DS: dioptre sphere, DC: dioptre cylinder.
Comparison across surgical techniques of presbyopic correction
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Monovision | 514 | 6M-5Y | 20/20 | J1 | --- | --- | --- | --- | 17% | 5% |
| 87% > 20/25 | 90% > J2 | |||||||||
| Multifocal | 234 | 6M-2Y | 20/20 | J4 | J5 | 12% < −2lns | 11% < −2lns | 76% ± 0.5DS | 21% | --- |
| 87% > 20/25 | 81% > J3 | 49% > +2lns | ||||||||
| LBV | 670 | 1Y | 20/17 | J3 | --- | 0% < −2lns | --- | 88% ± 0.5DS | 19% | --- |
| 99% > 20/25 | 91% > J3 | 86% ± 0.5DC | ||||||||
| Supracor | 169 | 6M | 20/23 | J2-J3 | --- | 9% < −2lns | 0% < −2lns | 54% ± 0.5DS | 13% | --- |
| 58% > 20/25 | 90% > J3 | 46% ± 0.5DC | ||||||||
| Intracor | 189 | 6M-18M | 20/24 | J3 | J2 | 9% < −2lns | 11% < −2lns | --- | --- | --- |
| 77% > 20/25 | 66% > J2 | |||||||||
| KAMRA | 166 | 6M-4Y | 20/17 | J3 | --- | 5% < −2lns | 5% < −2lns | --- | 1% | 6% |
| 93% > 20/25 | 73% > J2 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, Refr. Outc.: refractive outcome, Retreat.: retreatment rate, M: months, Y: year(s), J: Jaeger scale for near vision, lns: Snellen lines, DS: dioptre sphere, DC: dioptre cylinder.